SCHEMBL2268303

SCHEMBL2268303

CCOc1ccc2c(c1)C(=O)c1ccccc1C2=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.64
L3MBTL1 Q9Y468 4/20 0.64
PTPRC P08575 2/20 0.55
ALDH1A1 P00352 3/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
LMNA P02545 2/20 0.55
MAPK1 P28482 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
KMT2A Q03164 2/20 0.53
CHRNA7 P36544 1/20 0.53
MEN1 O00255 1/20 0.51
GAA P10253 1/20 0.51
KDM4E B2RXH2 1/20 0.51
NSD2 O96028 1/20 0.51
HPGD P15428 1/20 0.51
HTT P42858 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
ELANE P08246 1/20 0.50
CDC25B P30305 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10887519 0.98 MAPT (0.67) MAPTL3MBTL1PTPRCALDH1A1NPC1
SCHEMBL10883121 0.94 MAPT (0.70) MAPTL3MBTL1PTPRCALDH1A1NPC1
SCHEMBL9429530 0.93 MAPT (0.60) MAPTL3MBTL1PTPRCALDH1A1NPC1
SCHEMBL9643489 0.89 MAPT (0.59) MAPTL3MBTL1PTPRCALDH1A1NPC1
SCHEMBL23051433 0.86 MAPT (0.60) MAPTL3MBTL1ALDH1A1NPC1RAB9A
SCHEMBL18015983 0.86 MAPT (0.69) MAPTL3MBTL1ALDH1A1NPC1RAB9A
SCHEMBL14288507 0.84 MAPT (0.72) MAPTL3MBTL1ALDH1A1NPC1RAB9A
SCHEMBL28483559 0.84 NQO1 (0.54) MAPTL3MBTL1PTPRCALDH1A1NPC1
SCHEMBL11367478 0.84 MAPT (0.62) MAPTL3MBTL1ALDH1A1NPC1RAB9A
SCHEMBL9627608 0.82 CDC25A (0.56) MAPTL3MBTL1PTPRCALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111956636-B Application of 2-substituted anthraquinone derivative in preparation of medicines for treating candida albicans infection 中国药科大学 2022-03-18 CN disclosed
CN-111956636-A Application of 2-substituted anthraquinone derivative in preparation of medicines for treating candida albicans infection 中国药科大学 2020-11-20 CN disclosed
US-7998360-B2 Electrolysis solution for electrolytic capacitor, and electrolytic capacitor MITSUBISHI CHEMICAL CORPORATION (JP) 2011-08-16 US disclosed
US-20090034160-A1 ELECTROLYSIS SOLUTION FOR ELECTROLYTIC CAPACITOR, AND ELECTROLYTIC CAPACITOR MITSUBISHI CHEMICAL CORPORATION (JP) 2009-02-05 US disclosed
EP-1947662-A1 ELECTROLYSIS SOLUTION FOR ELECTROLYTIC CAPACITOR, AND ELECTROLYTIC CAPACITOR Mitsubishi Chemical Corporation (JP) 2008-07-23 EP disclosed